Filing Details

Accession Number:
0001437749-19-018984
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-09-24 17:34:46
Reporting Period:
2018-05-16
Accepted Time:
2019-09-24 17:34:46
Original Submission Date:
2018-06-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029125 Sun Biopharma Inc. SNBP Pharmaceutical Preparations (2834) 870543922
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652797 W. Paul Schaffer 712 Vista Blvd #305
Waconia MN 55387
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-16 2,000 $0.00 94,420 No 4 P Direct
Common Stock Acquisiton 2018-05-16 11,756 $0.00 30,665 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Footnotes
  1. Reflects purchase of 5,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
  2. Pursuant to the "alternate conversion" under the Convertible Promissory Note, approximately $52,902 of outstanding principal and accrued but unpaid interest converted into 11,756 units at a price equal to $4.50 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
  3. Amended solely to correct balances to reflect reverse stock split effective November 7, 2017.